NCT04086446

Brief Summary

This study will evaluate the possible therapeutic effects of Transcranial Direct Current Stimulation (tDCS) in drug-naïve obsessive-compulsive disorder (OCD) patients, and the underlying neural mechanism by magnetic resonance imaging (MRI),transcranial magnetic stimulation and electroencephalography (TMS-EEG).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 11, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 5, 2019

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

4.8 years

First QC Date

September 8, 2019

Last Update Submit

May 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Yale-Brown Obsessive Compulsive Scale(Y-BOCS) score

    It assesses the severity of OCD symptoms. The Y-BOCS scale ranges from 0 to 40, with 0 being no symptoms and 40 being severe.The responder on Y-BOCS is defined as a Y-BOCS decrease at least 35% from the baseline at post-treatment.

    Up to 3 months

Secondary Outcomes (6)

  • Change in Obsessive Compulsive Inventory-Revised(OCI-R)

    Up to 3 months

  • Change in Beck Depression Inventory(BDI)

    Up to 3 months

  • Change in Beck Anxiety Inventory (BAI)

    Up to 3 months

  • Change in Perceived Stress Scale(PSS)

    Up to 3 months

  • Change in Pittsburgh sleep quality index(PSQI)

    Up to 3 months

  • +1 more secondary outcomes

Study Arms (2)

active tDCS

ACTIVE COMPARATOR

Cathode transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.

Device: high-definition transcranial direct current stimulation

sham tDCS

SHAM COMPARATOR

The sham transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.

Device: Sham tDCS

Interventions

The tDCS device will deliver a direct current of 1.5mA during 20 minutes. Cathode electrode will be localized in front of the right OFC on the Fp2 point according to the EEG international reference. Four anode electrodes will be placed around FP2 (i.e. Fpz, AFz, AF4, AF8)

active tDCS
Sham tDCSDEVICE

The same procedure will be applied except that the tDCS device will only deliver a current stimulation for the first and last 15 seconds.

sham tDCS

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age: 18-50 years old;
  • DSM-5 criteria for OCD;
  • Y-BOCS total score \> or = 16, discontinued medication for at least 8 weeks before tDCS stimulation.
  • \>or=9 years education

You may not qualify if:

  • Any axis I psychiatric disorder comorbidity
  • The inability to receive tDCS because of metallic implants, or history of seizures,or 3.history of head injury, or history of neurosurgery.
  • Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
  • Any current significant medical condition.
  • serious suicide risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Zhen Wang, PhD,MD

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-president

Study Record Dates

First Submitted

September 8, 2019

First Posted

September 11, 2019

Study Start

November 5, 2019

Primary Completion

August 30, 2024

Study Completion

December 30, 2024

Last Updated

May 15, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations